Eris Lifesciences Limited (ERIS.BO)
INR 1409.0
(1.39%)
INR 1409.0
(1.39%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 20.09 Billion | 16.61 Billion | 13.26 Billion | 11.92 Billion | 10.58 Billion | 9.67 Billion |
| Cost of Revenue | 9.66 Billion | 3.57 Billion | 2.6 Billion | 2.41 Billion | 1.78 Billion | 1.55 Billion |
| Gross Profit | 10.42 Billion | 13.04 Billion | 10.65 Billion | 9.5 Billion | 8.79 Billion | 8.12 Billion |
| Operating Expenses | 4.94 Billion | 8.82 Billion | 6.4 Billion | 5.62 Billion | 5.55 Billion | 5.01 Billion |
| Selling, General and Administrative Expenses | 2.5 Billion | 1.86 Billion | 1.32 Billion | 1.31 Billion | 1.66 Billion | 1.35 Billion |
| Research and Development Expenses | 57.18 Million | 61 Million | 327.38 Million | 50.92 Million | 41.96 Million | 41.12 Million |
| Other Expenses | 238.15 Million | 12.44 Million | 10.36 Million | 4.55 Million | 36.62 Million | 17.4 Million |
| Cost and Expenses | 14.9 Billion | 12.39 Billion | 9.01 Billion | 8.03 Billion | 7.34 Billion | 6.56 Billion |
| Operating Income | 5.18 Billion | 4.29 Billion | 4.31 Billion | 3.96 Billion | 3.27 Billion | 3.1 Billion |
| Interest Expense | 848.01 Million | 261.68 Million | 41.46 Million | 18.02 Million | 21.62 Million | 228.95 Million |
| Income Tax Expense | 341.85 Million | 304.83 Million | 364.09 Million | 393.62 Million | 348.43 Million | 262.11 Million |
| Earnings before Tax | 4.31 Billion | 4.04 Billion | 4.42 Billion | 3.94 Billion | 3.31 Billion | 3.17 Billion |
| Net Income | 3.91 Billion | 3.82 Billion | 4.06 Billion | 3.55 Billion | 2.96 Billion | 2.9 Billion |
| Earnings Per Share Basic | 28.82 | 28.10 | 29.89 | 26.16 | 21.61 | 21.15 |
| Earnings Per Share Diluted | 28.79 | 28.07 | 29.88 | 26.14 | 21.59 | 21.13 |
| Weighted Average Shares Outstanding | 136.01 Million | 135.97 Million | 135.87 Million | 135.78 Million | 137.18 Million | 137.51 Million |
| Weighted Average Shares Outstanding (Diluted) | 136.16 Million | 136.16 Million | 135.91 Million | 135.88 Million | 137.3 Million | 137.64 Million |
| Gross Margin | 0.52 | 0.79 | 0.80 | 0.80 | 0.83 | 0.84 |
| EBIT Margin | 0.35 | 0.33 | 0.37 | 0.36 | 0.36 | 0.36 |
| Profit Margin | 0.20 | 0.23 | 0.31 | 0.30 | 0.28 | 0.30 |
| EBITDA | 6.98 Billion | 5.48 Billion | 5.11 Billion | 4.39 Billion | 3.83 Billion | 3.76 Billion |
| Earnings Before Tax Margin | 0.26 | 0.26 | 0.33 | 0.33 | 0.31 | 0.32 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 7.38 Billion | 7.19 Billion | 5.5 Billion | 20.09 Billion | 4.83 Billion | 5 Billion |
| Cost of Revenue | 1.86 Billion | 3.89 Billion | 2.74 Billion | 9.66 Billion | 888.69 Million | 945.97 Million |
| Gross Profit | 5.52 Billion | 3.3 Billion | 2.76 Billion | 10.42 Billion | 3.94 Billion | 4.05 Billion |
| Operating Expenses | 3.68 Billion | 1.56 Billion | 1.81 Billion | 5.5 Billion | 2.64 Billion | 2.66 Billion |
| Selling, General and Administrative Expenses | 1.64 Billion | 1.56 Billion | 1.81 Billion | - | 1.23 Billion | 1.31 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 3.68 Billion | 16.4 Million | 151.48 Million | 238.15 Million | 41.97 Million | 34.81 Million |
| Cost and Expenses | 5.54 Billion | 5.45 Billion | 4.56 Billion | 15.16 Billion | 3.53 Billion | 3.61 Billion |
| Operating Income | 1.84 Billion | 1.74 Billion | 945.31 Million | 4.92 Billion | 1.33 Billion | 1.39 Billion |
| Interest Expense | 594.7 Million | 603.7 Million | 330.32 Million | 848.01 Million | 181.18 Million | 162.95 Million |
| Income Tax Expense | 327.6 Million | 259 Million | -29.86 Million | 341.85 Million | 144.12 Million | 39.24 Million |
| Earnings before Tax | 1.29 Billion | 1.15 Billion | 766.47 Million | 4.31 Billion | 1.15 Billion | 1.26 Billion |
| Net Income | 915.9 Million | 831.8 Million | 709.62 Million | 3.91 Billion | 1.02 Billion | 1.23 Billion |
| Earnings Per Share Basic | 6.73 | 6.11 | 5.22 | - | 7.55 | 9.07 |
| Earnings Per Share Diluted | 6.72 | 6.10 | 5.21 | - | 7.54 | 9.06 |
| Weighted Average Shares Outstanding | 136.09 Million | 136.07 Million | 136.02 Million | 136.01 Million | 136.02 Million | 136.02 Million |
| Weighted Average Shares Outstanding (Diluted) | 136.29 Million | 136.36 Million | 136.25 Million | 136.15 Million | 136.25 Million | 136.23 Million |
| Gross Margin | 0.75 | 0.46 | 0.50 | 0.52 | 0.82 | 0.81 |
| EBIT Margin | 0.36 | 0.35 | 0.27 | - | 0.37 | 0.37 |
| Profit Margin | 0.12 | 0.12 | 0.13 | 0.20 | 0.21 | 0.25 |
| EBITDA | 2.69 Billion | 2.49 Billion | 1.48 Billion | - | 1.79 Billion | 1.84 Billion |
| Earnings Before Tax Margin | 0.25 | 0.24 | 0.17 | 0.24 | 0.28 | 0.28 |
PAEKY
VPT
FLUIDOM
BCDMF
TELECANOR
0REZ